Embryonic Neural Stem Cells

Embryonic neural stem cells can be used to investigate the effect of different toxins and molecules on the proliferation and differentiation of these cells. Discover the latest research of embryonic neural stem cells here.

September 16, 2021

MiRNA-149 as a Candidate for Facial Clefting and Neural Crest Cell Migration.

Journal of Dental Research
L G StüsselK U Ludwig
September 13, 2021
Open Access

p57Kip2 regulates embryonic haematopoietic stem cell numbers by controlling the size of the sympathoadrenal progenitor pool

BioRxiv : the Preprint Server for Biology
C. KapeniKatrin Ottersbach
September 11, 2021

The protective effects of neural stem cells and neural stem cells-conditioned medium against inflammation-induced prenatal brain injury.

Journal of Neuroimmunology
Maryam Borhani-Haghighi, Yousef Mohamadi
September 10, 2021
Open Access

Generation of Multipotential NG2 Progenitors From Mouse Embryonic Stem Cell-Derived Neural Stem Cells.

Frontiers in Cell and Developmental Biology
Masahiro OtsuDaniel Fulton
September 9, 2021
Open Access

RBBP4 modulates gene activity through acetylation and methylation of histone H3 lysine 27

BioRxiv : the Preprint Server for Biology
W. MuTerry Magnuson
September 7, 2021

Di-n-butyl phthalate disrupts neuron maturation in primary rat embryo neurons and male C57BL/6 mice.

Journal of Toxicology and Environmental Health. Part a
Seulah LeeJaewon Lee
September 6, 2021

Coordination of EZH2 and SOX2 specifies human neural fate decision.

Cell Regeneration
Yuan ZhaoGuangjin Pan
September 6, 2021

Levetiracetam promoted rat embryonic neurogenesis via NMDA receptor-mediated mechanism in vitro.

Life Sciences
Mohaddeseh Sadat AlaviHamid R Sadeghnia
September 4, 2021

Neuroepithelial progenitors generate and propagate non-neuronal action potentials across the spinal cord.

Current Biology : CB
Kalaimakan Hervé ArulkandarajahJean-Marie Mangin
September 2, 2021

Adrenal cortex development and maintenance; knowledge acquired from mouse models.

Nour Abou Nader, Alexandre Boyer
September 2, 2021

Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder.

Nature Communications
Job O de JongSander Markx
August 28, 2021
Open Access

Morphological and Functional Changes of Roof Plate Cells in Spinal Cord Development.

Journal of Developmental Biology
Takuma Shinozuka, Shinji Takada
August 27, 2021
Open Access

The Transcription Factor NF-κB in Stem Cells and Development.

Christian KaltschmidtBarbara Kaltschmidt
August 27, 2021
Open Access

Prevention of Teratogenesis in Pregnancies of Obese Rats by Vitamin E Supplementation.

Martin AlcalaMarta Viana
August 26, 2021
Open Access

Integrated single-cell analysis of enteric glial cells reveals a molecular basis for postnatal neurogenesis and its therapeutic application

BioRxiv : the Preprint Server for Biology
R. A. GuyerAllan M Goldstein
August 25, 2021

Developmental HCN channelopathy results in decreased neural progenitor proliferation and microcephaly in mice.

Proceedings of the National Academy of Sciences of the United States of America
Anna Katharina SchluscheDirk Isbrandt

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved